(Q36960178)

17 August 2017

1 reference

title

Treatment of patients comorbid for addiction and other psychiatric disorders (English)

1 reference

17 August 2017

Kathleen T Brady

1

1 reference

17 August 2017

Marcia L Verduin

series ordinal

2

1 reference

17 August 2017

Bryan K Tolliver

series ordinal

3

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

Current Psychiatry Reports

17 August 2017

published in

1 reference

17 August 2017

volume

9

1 reference

17 August 2017

issue

5

1 reference

17 August 2017

page(s)

374-380

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

17 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-007-0048-0

Antipsychotic treatment discontinuation among individuals with schizophrenia and co-occurring substance use

21 January 2018

1 reference

12 December 2020

Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders

1 reference

12 December 2020

A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence

1 reference

12 December 2020

Aripiprazole in schizophrenia with cocaine dependence: a pilot study

1 reference

12 December 2020

Intranasal quetiapine abuse

1 reference

12 December 2020

The Role of Psychiatric Disorders in Predicting Drug Dependence Treatment Outcomes

1 reference

12 December 2020

A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

1 reference

12 December 2020

Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia

1 reference

12 December 2020

Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

1 reference

12 December 2020

The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial

1 reference

12 December 2020

Naltrexone in patients with bipolar disorder and alcohol dependence.

1 reference

12 December 2020

Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis

1 reference

12 December 2020

Cannabis and psychosis: an update on course and biological plausible mechanisms

1 reference

12 December 2020

Treatment responsivity of cocaine-dependent patients with antisocial personality disorder to cognitive-behavioral and contingency management interventions

1 reference

12 December 2020

The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R)

1 reference

12 December 2020

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

1 reference

12 December 2020

Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants

1 reference

12 December 2020

Effect of topiramate augmentation on two patients suffering from schizophrenia or bipolar disorder with comorbid alcohol abuse

1 reference

12 December 2020

Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS).

1 reference

12 December 2020

Significant interaction between clozapine and cocaine in cocaine addicts

1 reference

12 December 2020

Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study

1 reference

12 December 2020

Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol

1 reference

12 December 2020

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

12 December 2020

Promising treatments for women with comorbid PTSD and substance use disorders

1 reference

12 December 2020

Atypical antipsychotic medication and substance use-related outcomes in the treatment of schizophrenia

1 reference

12 December 2020

Unlinking disability income, substance use and adverse outcomes in dually diagnosed, severely mentally ill outpatients.

1 reference

12 December 2020

Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders

1 reference

12 December 2020

Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions

1 reference

12 December 2020

Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions

1 reference

12 December 2020

Does assigning a representative payee reduce substance abuse?

1 reference

12 December 2020

Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action

1 reference

12 December 2020

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study

1 reference

12 December 2020

Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches

1 reference

12 December 2020

DSM-IV personality disorders in the National Comorbidity Survey Replication

1 reference

12 December 2020

Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions

1 reference

12 December 2020

Effects of lamotrigine in patients with bipolar disorder and alcohol dependence.

1 reference

12 December 2020

Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania

1 reference

12 December 2020

Naltrexone and Disulfiram in Patients with Alcohol Dependence and Comorbid Post-Traumatic Stress Disorder

1 reference

12 December 2020

A longitudinal study of the order of onset of alcohol dependence and major depression

1 reference

12 December 2020

The role of personality disorders on drug dependence treatment outcomes following inpatient detoxification

1 reference

12 December 2020

Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension study

1 reference

12 December 2020

Does recovery from substance use disorder matter in patients with bipolar disorder?

1 reference

12 December 2020

Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity

1 reference

12 December 2020

Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.

1 reference

12 December 2020

Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram

1 reference

12 December 2020

Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole.

1 reference

12 December 2020

10.1007/S11920-007-0048-0

Identifiers

DOI

1 reference

17 August 2017

1 reference